Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell therapy and amniotic membrane for chronic diabetic wound healing
IRCT20191007045008N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Stem Cell Therapies → Cell Therapies, Tissue Cells → Other Cell Types → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of adipose derived mesenchymal stromal cells and biological amniotic membrane in diabetic foot ulcer (DFU) and Chronic wound (4 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Ulcer healing rate. Started Oct 2019; status: completed.
02
Drugs
adipose derived mesenchymal stromal cellsbiological amniotic membrane
03
Conditions
diabetic foot ulcer (DFU)Chronic wound
Beyond the preview
Go deeper on IRCT20191007045008N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191007045008N1.